Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets
Mayank Dalakoti,
Salim Virani
Affiliations
Mayank Dalakoti
Department of Cardiology, National University Heart Centre, Singapore; Department of Medicine, Ng Teng Fong General Hospital, Singapore; Department of Public Health and Primary Care, University of Cambridge, United Kingdom; Corresponding author.
Salim Virani
Department of Medicine, The Aga Khan University, Karachi, Pakistan; The Texas Heart Institute, Houston, TX, USA; Section of Cardiovascular Research, Baylor College of Medicine, USA
